Brookfield Business Corp is the operator of vital industrial and business services operations... Show more
Brookfield Business Corporation occupies a distinctive niche in the global industrials and business services landscape. Rather than operating as a conventional single-line industrial company, BBUC functions as the flagship publicly traded vehicle of Brookfield Asset Management's Private Equity Group — a permanent capital platform that acquires controlling stakes in market-leading businesses, drives operational improvements, and recycles capital when mature holdings can be sold at attractive valuations.
The portfolio spans three core segments: Industrials, anchored by Clarios (the global leader in low-voltage automotive batteries, powering approximately one in three vehicles worldwide); Business Services, which includes Sagen (Canada's largest private residential mortgage insurer), CDK Global (mission-critical dealership software), Nielsen (audience measurement), and Scientific Games (lottery systems); and Infrastructure Services, comprising water and wastewater operations in Brazil, construction services, and work access solutions. This diversification across geographies — with meaningful exposure to the United States, Australia, the United Kingdom, Brazil, and Europe — provides natural shock absorbers against regional economic softness.
Brookfield's competitive moat rests not on any single product but on its demonstrated ability to buy complex businesses, professionalize operations, and compound capital at mid-teens rates over time. Since inception, the firm has executed more than 25 monetizations, generating over $8 billion in cumulative proceeds while achieving a realized multiple of roughly two times invested capital. The recently completed corporate simplification — which merged the legacy BBU partnership and BBUC corporate structures into a single Canadian corporation in March 2026 — is a structural catalyst designed to close the persistent discount between BBUC's trading price and management's estimate of net asset value (NAV) by making the shares accessible to a broader global investor base and eligible for inclusion in additional equity indices.
Several near- and medium-term catalysts could meaningfully influence BBUC's stock trajectory and investor sentiment.
Q2 2026 Earnings (Expected July 31, 2026): The upcoming quarterly report represents the next major checkpoint for the market to assess whether underlying same-store EBITDA (earnings before interest, taxes, depreciation, and amortization) growth — which rose approximately 5% year-over-year in Q1 on a comparable basis — is sustaining momentum across the Industrials and Business Services segments. Investors will also scrutinize any updated commentary on Clarios' pathway toward potentially doubling in value over five years, a thesis management outlined during the Q1 call based on mid-single-digit organic EBITDA growth, tax credit cash flows, and deleveraging.
Clarios Monetization Optionality: Management has signaled that Clarios, currently representing roughly 30% of BBUC's estimated NAV (net asset value, or approximately $15 per share), could double its contribution over five years if it reaches $3 billion in annual EBITDA. While the company has described Clarios as a "cash compounder" it is in no hurry to exit, any partial monetization event — such as an initial public offering or strategic stake sale — would likely serve as a significant value-realization catalyst.
Further Capital Recycling Transactions: The successful minority sale of La Trobe Financial at a $2 billion valuation (3x multiple, 35% IRR, or internal rate of return) demonstrates the portfolio's embedded value. Potential future monetization candidates include BRK Ambiental in Brazil, where management has evaluated IPO (initial public offering) timing, and other mature assets. Proceeds from such sales feed directly back into the capital recycling flywheel, funding new acquisitions and share repurchases.
Analyst Sentiment and Price Targets: According to S&P Global Market Intelligence, seven analysts currently cover BBUC with a consensus "Buy" rating and an average price target of approximately $41 — implying notable upside from recent trading levels. Firms including BMO Capital, Scotiabank, RBC Capital, and CIBC maintain Outperform or Buy ratings. Price targets cluster in a range of $34 to $45, with BMO Capital recently raising its target to $45. TD Cowen initiated coverage with a Hold rating and a $34 target in June 2026, representing a more cautious view. The absence of Sell ratings among major firms suggests broad institutional confidence, though the spread in targets reflects genuine uncertainty around the pace of earnings normalization post-restructuring.
BBUC's trajectory is intricately linked to several macroeconomic and industry-level dynamics. On the interest-rate front, the portfolio carries substantial leverage — approximately $45.6 billion in total debt against $5.26 billion in cash — making the cost of refinancing a critical variable. Encouragingly, Brookfield completed over $20 billion in financings across its portfolio during 2025, reducing the cost of refinanced borrowings by more than 50 basis points. Should central banks sustain a gradual easing cycle, further reductions in interest expense could provide a tailwind to free cash flow.
The health of the Canadian housing market is another important sensitivity through the Sagen mortgage insurance business. Canadian home prices have declined, pushing Sagen's loss ratio from historically low single-digit levels toward approximately 12% in early 2026. Management projects the loss ratio will remain comfortably below the long-run pricing target of 15% to 20%, and Sagen's portfolio quality remains robust — average new-loan credit scores exceed 760, and roughly 80% of mortgages are fixed-rate. Still, further deterioration in Canadian employment or housing could pressure this segment.
On the industrial side, Clarios benefits from secular growth in advanced absorbent glass mat (AGM) batteries, which command higher margins and are gaining share as vehicle electrification and start-stop technology proliferate. The U.S. policy environment — specifically the 45X advanced manufacturing production tax credit under the Inflation Reduction Act — has emerged as a transformative financial tailwind, effectively providing Clarios with a predictable $1 billion annual cash inflow. Meanwhile, European industrial activity remains soft, though management has noted early signs of stabilization supported by fiscal spending in Germany and more accommodative monetary policy.
Technology adoption trends, particularly around artificial intelligence, are creating new opportunity sets. Brookfield's DeployCo partnership with OpenAI targets one of the primary bottlenecks in AI adoption — moving from pilot programs to enterprise-wide implementation — and could unlock productivity gains across BBUC's operating companies, spanning manufacturing, software, insurance, and infrastructure services.
Navigating the complex interplay of macroeconomic forces, capital recycling events, and segment-level operational performance that shapes BBUC's outlook requires timely and data-driven insight. Tickeron's Trend Prediction Engine is an AI-powered forecasting tool designed to help traders identify whether a stock, ETF, or other tradable instrument may trend bullish, bearish, or sideways over the coming week or month. By analyzing historical patterns, momentum signals, and predictive indicators, the platform helps users spot developing trends, evaluate potential breakouts or reversals, and access predictions across a wide universe of instruments. The engine organizes predictions into searchable categories with historical context and alert-oriented functionality, making it a practical resource for investors seeking to complement fundamental analysis with data-driven technical signals.
Looking toward the remainder of 2026 and beyond, several long-term structural themes will likely define BBUC's value-creation trajectory. The corporate simplification completed in March is expected to produce compounding benefits: management anticipates approximately 5 million shares of incremental demand from index rebalancing, and trading volumes have already risen roughly 40% since the reorganization. If the simplification narrows the persistent discount to NAV, the re-rating could represent a meaningful source of shareholder returns independent of operational performance.
Clarios remains the centerpiece of the long-term thesis. Management's bridge to a potential doubling of value — built on mid-single-digit organic EBITDA growth, cumulative free cash flow exceeding $8 billion over five years (including tax credits), and significant deleveraging — provides a quantifiable framework for investors. The 45X credits are particularly consequential: at approximately $1.50 per BBUC share annually, they represent a durable, policy-backed cash stream that funds reinvestment, debt reduction, and ultimately capital returns to shareholders.
The DeployCo partnership with OpenAI introduces an early-stage but strategically significant growth vector. By embedding AI deployment capabilities across more than 300 operating companies, Brookfield aims to accelerate productivity gains, automate workflows, and improve decision-making at portfolio companies spanning manufacturing, software, insurance, and infrastructure. While the financial contribution is unlikely to be material in the near term, the initiative signals management's intent to position BBUC at the intersection of industrial operations and AI-driven transformation.
Capital allocation discipline — demonstrated through the $250 million share repurchase program, selective acquisitions such as Fosber (a global leader in corrugated packaging machinery), and opportunistic monetizations — will remain central to the investment case. With pro forma corporate liquidity of approximately $2.4 billion and a demonstrated ability to execute across market cycles, BBUC enters the second half of 2026 with ample strategic flexibility. Consensus analyst expectations, as captured by S&P Global, project fiscal 2026 earnings per share of approximately $1.74, with that figure rising to $2.42 in 2027 — suggesting that the market is pricing in a meaningful earnings recovery as capital recycling proceeds and operational improvements mature across the portfolio.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Industry IndustrialConglomerates
A.I.dvisor indicates that over the last year, BBUC has been loosely correlated with BN. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if BBUC jumps, then BN could also see price increases.
| Ticker / NAME | Correlation To BBUC | 1D Price Change % | ||
|---|---|---|---|---|
| BBUC | 100% | -2.18% | ||
| BN - BBUC | 64% Loosely correlated | +0.45% | ||
| BAM - BBUC | 57% Loosely correlated | +0.67% | ||
| IVZ - BBUC | 54% Loosely correlated | +0.51% | ||
| PFG - BBUC | 54% Loosely correlated | +0.36% | ||
| CRBG - BBUC | 53% Loosely correlated | +2.40% | ||
More | ||||
| Ticker / NAME | Correlation To BBUC | 1D Price Change % |
|---|---|---|
| BBUC | 100% | -2.18% |
| Industrial Conglomerates industry (28 stocks) | 15% Poorly correlated | +4.98% |
| Producer Manufacturing industry (350 stocks) | 4% Poorly correlated | +1.35% |
BBUC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 32 cases where BBUC's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BBUC advanced for three days, in of 248 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 47 cases where BBUC's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
The Momentum Indicator moved below the 0 level on August 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BBUC as a result. In of 77 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for BBUC turned negative on August 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at .
BBUC moved below its 50-day moving average on July 30, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BBUC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for BBUC entered a downward trend on July 17, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.087) is normal, around the industry mean (6.471). P/E Ratio (0.000) is within average values for comparable stocks, (68.079). BBUC's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.514). Dividend Yield (0.009) settles around the average of (0.030) among similar stocks. P/S Ratio (0.089) is also within normal values, averaging (2.432).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. BBUC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BBUC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock worse than average.